Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opus Genetics (IRD) Change in Receivables (2022 - 2026)

Opus Genetics has reported Change in Receivables over the past 5 years, most recently at -$264000.0 for Q1 2026.

  • Quarterly Change in Receivables rose 45.34% to -$264000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$1.3 million through Mar 2026, down 216.7% year-over-year, with the annual reading at -$1.6 million for FY2025, 159.46% down from the prior year.
  • Change in Receivables was -$264000.0 for Q1 2026 at Opus Genetics, up from -$921000.0 in the prior quarter.
  • Over five years, Change in Receivables peaked at $10.0 million in Q3 2023 and troughed at -$9.2 million in Q4 2023.
  • The 5-year median for Change in Receivables is $27500.0 (2025), against an average of $123642.9.
  • Year-over-year, Change in Receivables plummeted 809.24% in 2023 and then soared 156.36% in 2025.
  • A 5-year view of Change in Receivables shows it stood at $1.3 million in 2022, then plummeted by 809.24% to -$9.2 million in 2023, then soared by 118.53% to $1.7 million in 2024, then tumbled by 153.99% to -$921000.0 in 2025, then surged by 71.34% to -$264000.0 in 2026.
  • Per Business Quant, the three most recent readings for IRD's Change in Receivables are -$264000.0 (Q1 2026), -$921000.0 (Q4 2025), and -$483000.0 (Q3 2025).